Similar articles

• Multidrug resistance: molecular biology and clinical relevance.

  Rothenberg M, Ling V. Rothenberg M, et al. J Natl Cancer Inst. 1989 Jun 21;81(12):907-10. doi: 10.1093/jnci/81.12.907. J Natl Cancer Inst. 1989. PMID: 2567355 No abstract available.
• Multidrug resistance in human cancer.

  Goldstein LJ, Pastan I, Gottesman MM. Goldstein LJ, et al. Crit Rev Oncol Hematol. 1992;12(3):243-53. doi: 10.1016/1040-8428(92)90057-w. Crit Rev Oncol Hematol. 1992. PMID: 1353966 Review. No abstract available.
• [Tumor resistance to multiple antineoplastic agents mediated by glycoprotein P: from the laboratory to the clinical field].

  González-Manzano R. González-Manzano R. Med Clin (Barc). 1994 Apr 9;102(13):506-15. Med Clin (Barc). 1994. PMID: 7911549 Review. Spanish. No abstract available.
• [Atypical MDR].

  Yokomizo A, Taniguchi K, Hasegawa S, Abe T, Kubo T, Makino Y, Wada M, Kohno K, Kuwano M. Yokomizo A, et al. Gan To Kagaku Ryoho. 1994 Jul;21(8):1123-9. Gan To Kagaku Ryoho. 1994. PMID: 7913311 Review. Japanese.
• Multidrug resistance in cancer.

  Ferry DR, Kerr DJ. Ferry DR, et al. BMJ. 1994 Jan 15;308(6922):148-9. doi: 10.1136/bmj.308.6922.148. BMJ. 1994. PMID: 7906169 Free PMC article. No abstract available.